Treatment with enzyme replacement therapy can help children with classic infantile Pompe disease reach adulthood. However, it fails to prevent the long-term effects of the disease in the brain and consequent  development of intellectual disabilities, a study shows. The study titled “Classic infantile Pompe patients…
ERT
Duke Health researchers are planning to launch a Phase 1 trial to test the safety of a new investigational gene therapy they developed to treat patients with Pompe disease. They are currently screening (NCT03285126) adults with late-onset Pompe disease to select eligible participants for the upcoming trial.
Recent Posts
- Part of our journey was learning how to talk to our children about Pompe
- Early Pompe disease treatment means better heart health: Study
- MDA 2026: Keynote speaker to MDA community: ‘Your voice is powerful’
- I enforce lifesaving care to protect my child now and prepare her for the future
- Sugar marker found in urine could help track progression in LOPD: Study